4//SEC Filing
Robb Gary Charles 4
Accession 0001193125-25-196309
CIK 0001088856other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 7:51 PM ET
Size
11.3 KB
Accession
0001193125-25-196309
Insider Transaction Report
Form 4
Robb Gary Charles
Chief Financial Officer
Transactions
- Award
Common Stock
2025-09-02$71.38/sh+251$17,916→ 13,615 total - Award
Common Stock
2025-09-02+251→ 13,866 total - Tax Payment
Common Stock
2025-09-03$71.38/sh−256$18,273→ 13,610 total
Holdings
- 11,571(indirect: By Children)
Common Stock
- 11,571(indirect: By Children)
Common Stock
Footnotes (8)
- [F1]The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 2, 2025.
- [F2]In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
- [F3]Includes 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- [F4]Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.
- [F5]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
- [F6]The closing price on September 2, 2025 was used to calculate the withholding obligation.
- [F7]These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
- [F8]These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001529655
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 7:51 PM ET
- Size
- 11.3 KB